These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37808343)

  • 1. Exploring programmatic indicators of tuberculosis control that incorporate routine
    Zhang X; Martinez E; Lam C; Crighton T; Sim E; Gall M; Donnan EJ; Marais BJ; Sintchenko V
    Lancet Reg Health West Pac; 2023 Dec; 41():100910. PubMed ID: 37808343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis.
    Hall MB; Rabodoarivelo MS; Koch A; Dippenaar A; George S; Grobbelaar M; Warren R; Walker TM; Cox H; Gagneux S; Crook D; Peto T; Rakotosamimanana N; Grandjean Lapierre S; Iqbal Z
    Lancet Microbe; 2023 Feb; 4(2):e84-e92. PubMed ID: 36549315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.
    Oostvogels S; Ley SD; Heupink TH; Dippenaar A; Streicher EM; De Vos E; Meehan CJ; Dheda K; Warren R; Van Rie A
    Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35471145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection.
    Lam C; Martinez E; Crighton T; Furlong C; Donnan E; Marais BJ; Sintchenko V
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S48-S54. PubMed ID: 33753222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Five User-Friendly Whole Genome Sequencing Software for
    Kim N; Seok KH; Shin S; Kim B; Park H; Roh EY; Yoon JH; Shin S
    J Korean Med Sci; 2022 Nov; 37(46):e328. PubMed ID: 36631026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing.
    Parvaresh L; Crighton T; Martinez E; Bustamante A; Chen S; Sintchenko V
    BMC Infect Dis; 2018 Jun; 18(1):265. PubMed ID: 29879906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.
    He W; Tan Y; Liu C; Wang Y; He P; Song Z; Liu D; Zheng H; Ma A; Zhao B; Ou X; Xia H; Wang S; Zhao Y
    Microbiol Spectr; 2022 Feb; 10(1):e0154321. PubMed ID: 35171016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia.
    Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S
    Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome sequencing for rapid, reliable and routine investigation of
    Zakham F; Laurent S; Esteves Carreira AL; Corbaz A; Bertelli C; Masserey E; Nicod L; Greub G; Jaton K; Mazza-Stalder J; Opota O
    New Microbes New Infect; 2019 Sep; 31():100582. PubMed ID: 31388433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai.
    Zade A; Shah S; Hirani N; Kondabagil K; Joshi A; Chatterjee A
    J Glob Antimicrob Resist; 2022 Dec; 31():256-262. PubMed ID: 36272707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic-based surveillance reveals high ongoing transmission of multi-drug-resistant Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Reis AJ; Schiefelbein SH; Gómez MAA; Salvato SS; da Silva LV; Costa ERD; Unis G; Dias CF; Viveiros M; Portugal I; von Groll A; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Int J Antimicrob Agents; 2021 Oct; 58(4):106401. PubMed ID: 34289403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.